Semax is a synthetic heptapeptide analog derived from a specific fragment of adrenocorticotropic hormone (ACTH 4-10). At the biochemical level, Semax is primarily studied for its role in modulating neurochemical signaling pathways and influencing the expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF). In experimental models, this peptide is utilized to investigate peptidase inhibition and the subsequent stabilization of endogenous signaling molecules. Laboratory research frequently employs Semax in vitro to explore neurochemical receptor kinetics, gene expression regulation in isolated neuronal cells, and fundamental cellular responses to neurotrophic modulation.